8-K 1 v76866e8-k.txt 8-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 --------------------- FORM 8-K --------------------- CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 --------------------- November 5, 2001 Date of Report (Date of earliest event reported) INTERNATURAL PHARMACEUTICALS, INC. ---------------------------------------------- (Name of Small Business Issuer in its charter) Nevada 52-2265135 --------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4201 Wilshire Boulevard, Suite 525 Los Angeles, California 90010 --------------------------------------- -------- (Address of principal executive offices) (Zip code) Registrant's telephone number, including area code: (323) 954-9808 Not Applicable ------------------------------------------------------------------------------ (Former name or former address, if changed since last report) Item 5. Other Events. SHARE DISTRIBUTION InterNatural Pharmaceuticals, Inc. ("Company"), by unanimous written consent of its Board of Directors dated November 5, 2001, has approved the distribution of one (1) share of its wholly-owned subsidiary, Checkpoint Genetics Group, Inc., to each Company stockholder on record as of September 30, 2001. The distribution shall take effect no later than November 30, 2001. As a result of the distribution, all Company shareholders of record on September 30, 2001 will become shareholders of the subsidiary. SUBSIDIARY NAME CHANGE On November 5, 2001, Checkpoint Genetics Group, Inc., the Company's subsidiary mentioned hereinabove, has approved a change in its name to "HealthTech Group, Inc." Said approval was obtained by and through a unanimous written consent of its Board of Directors. This change will take effect immediately upon approval by the Secretary of State of Nevada. ANNOUNCEMENT OF ANNUAL SHAREHOLDERS MEETING The Company, by unanimous written consent of its Board of Directors and pursuant to its by-laws, has scheduled the annual meeting of shareholders for the first week of May 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 6, 2001 INTERNATURAL PHARMACEUTICALS, INC. By: /s/ Lucille Abad -------------------------- Lucille Abad President

U.S. SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

October 15, 2001 Date of Report (Date of earliest event reported)

INTERNATURAL PHARMACEUTICALS, INC. (Name of Small Business Issuer in its charter)

Nevada		52-2265135
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
4201 Wilshire Boulevard, Suite 525
Los Angeles, California		90010
(Address of principal executive offices)		(Zip code)

Registrant’s telephone number, including area code: (323) 954-9808

Not Applicable (Former name or former address, if changed since last report)

TABLE OF CONTENTS

Item 5. Other Events SIGNATURE

Item 5. Other Events

On October 15, 2001, the Board of Directors of InterNatural Pharmaceuticals, Inc., (“the Company”) appointed Mr. Raul John Tañedo as an additional Director and the Company accepted the resignation of Mr. Valentino Guzman as Secretary and Treasurer.

On the same day, the Board of Directors appointed Mr. Roy Rayo as Secretary and Mr. Raul John Tañedo as Treasurer of the Company.

Mr. Raul John Tañedo, a Certified Public Accountant and an attorney, is managing partner of Guzman and Tanedo Law Office based in Makati City, Manila. Before becoming managing partner, he was an associate attorney at Medel, Macam, Pineda & Larcia Law Offices and at the law firm of Juarez & Olivas-Gallo. He also served as officer-in-charge for Planning and Research and for Audit and Verification of the One Stop Shop Tax Credit and Duty Drawback Center of the Philippine Department of Finance.

Mr. Roy Rayo is the newly appointed Secretary of the Company. From September 1997 through May 2000, Mr. Rayo was an associate attorney at SyCip Salazar Hernandez & Gatmaitan in Makati City, Metro Manila, Philippines, where he assisted in prosecution and maintenance of trademark applications and registrations. From April through August 1997, Mr. Rayo was a law clerk in the Circuit Court of the Second Circuit in Maui, Hawaii. From January through March 1997, Mr. Rayo was a Legal Analyst at the House of Representatives for the State of Hawaii. From June through July 1994, Mr. Rayo was an intern at the United Nations Economic and Social Commission for Asia and the Pacific, Bangkok, Thailand.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 31, 2001	InterNatural Pharmaceuticals, Inc.
	By:	/s/ Lucille Abad
		Lucille Abad Director/President

Table of Contents

Table of Contents

Filing Compare · INTERNATURAL PHARMACEUTICALS INC